The rapidly evolving research on vitamin D among HIV-infected populations

Current Infectious Disease Reports

Volumn 13, Issue 1, 2011, Pages 83-93

  Overton, Edgar Turner ^a   Yin, Michael T ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

AIDS; Bone health; HIV; Vitamin D

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; ANTIRETROVIRUS AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; CYTOCHROME P450; DARUNAVIR; EFAVIRENZ; EMTRICITABINE; GLUCOSE; NEVIRAPINE; OSTEOCALCIN; PROTEINASE INHIBITOR; TENOFOVIR; VITAMIN D; VITAMIN D RECEPTOR; ZIDOVUDINE;

ACCIDENT PREVENTION; ADAPTIVE IMMUNITY; AGING; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE METABOLISM; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSLIPIDEMIA; ENERGY METABOLISM; FALLING; FEMUR FRACTURE; FEMUR SUBTROCHANTERIC FRACTURE; FRACTURE; GASTROINTESTINAL DISEASE; GLUCOSE METABOLISM; HIP FRACTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; IMMUNE RESPONSE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; JAW OSTEONECROSIS; KIDNEY DISEASE; LIFE EXPECTANCY; LOW DRUG DOSE; MEDICAL RESEARCH; MORTALITY; MUSCLE STRENGTH; NONHUMAN; OSTEOMALACIA; OSTEOPENIA; OSTEOPOROSIS; PANCREAS FUNCTION; PARATHYROID HORMONE BLOOD LEVEL; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; TUBULAR DYSFUNCTION; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION;

EID: 79551530696     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-010-0144-x     Document Type: Article

References (115)

1. FJ Palella RK Baker AC Moorman, et al. 2006 Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study J Acquir Immune Defic Syndr. 43 1 27 34 1:CAS:528:DC%2BD28XosFGmtro%3D 10.1097/01.qai.0000233310.90484.16 16878047 (Pubitemid 44306484)
2. FC Lampe CJ Smith S Madge, et al. 2007 Success of clinical care for human immunodeficiency virus infection according to demographic group among sexually infected patients in a routine clinic population, 1999 to 2004 Arch Intern Med. 167 7 692 700 10.1001/archinte.167.7.692 17420428 (Pubitemid 46598462)
3. KP Bhavan VN Kampalath ET Overton 2008 The aging of the HIV epidemic Curr HIV/AIDS Rep. 5 3 150 158 10.1007/s11904-008-0023-3 18627664
4. P Tebas WG Powderly S Claxton, et al. 2000 Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy AIDS 14 F63 F67 1:CAS:528:DC%2BD3cXis1egu7w%3D 10.1097/00002030-200003100-00005 10770534 (Pubitemid 30182458)
5. TT Brown RB Qaqish 2006 Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review AIDS. 20 2165 2174 10.1097/QAD.0b013e32801022eb 17086056 (Pubitemid 44684707)
6. VA Triant TT Brown H Lee SK Grinspoon 2008 Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system J Clin Endocrinol Metab 93 9 3499 3504 1:CAS:528:DC%2BD1cXhtFChurnE 10.1210/jc.2008-0828 18593764 This article is the first research paper to illustrate that the low bone mineral density among HIV-infected persons leads to fragility fractures
7. GA McComsey P Tebas E Shane, et al. 2010 Bone Disease in HIV: A Practical Review and Recommendations for HIV Providers CID 51 937 946 10.1086/656412 This article is a recent review of issues related to bone health for HIV care providers
8. AF Hess LF Unger 1921 The cure of infantile rickets by sunlight JAMA. 77 1 39 41
9. J Chalmers WDH Conacher DL Garnder PJ Scott 1967 Osteomalacia: a common disease in elderly women J Bone Joint Surg Br. 49 3 403 423 1:STN:280: DyaF2s3hvFWitw%3D%3D 6037558
10. MF Holick 2007 Vitamin D deficiency N Engl J Med. 357 3 266 281 1:CAS:528:DC%2BD2sXotVejsbc%3D 10.1056/NEJMra070553 17634462 (Pubitemid 47080391)
11. RP Heaney 2007 The case for improving vitamin D status J Steroid Biochem Mol Biol 103 3-5 635 641 1:CAS:528:DC%2BD2sXjt1Wnsbc%3D 10.1016/j.jsbmb.2006.12. 006 17222549 (Pubitemid 46401312)
12. P Lips T Duong A Oleksik, et al. 2001 A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial J Clin Endocrinol Metab. 86 1212 1221 1:CAS:528:DC%2BD3MXitFWnt7s%3D 10.1210/jc.86.3.1212 11238511 (Pubitemid 32323007)
13. MF Holick 2006 Resurrection of vitamin D deficiency and rickets J Clin Invest 116 2062 2072 1:CAS:528:DC%2BD28XnvF2msbs%3D 10.1172/JCI29449 16886050 (Pubitemid 44162310)
14. B Dawson-Hughes SS Harris EA Krall GE Dallal 1997 Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older N Engl J Med 337 670 676 1:CAS:528:DyaK2sXmt1Wqtbk%3D 10.1056/ NEJM199709043371003 9278463 (Pubitemid 27375473)
15. MF Holick 2006 High prevalence of vitamin D inadequacy and implications for health Mayo Clin Proc. 81 3 353 373 1:CAS:528:DC%2BD28XjtFeitb0%3D 10.4065/81.3.353 16529140
16. KE Broe TC Chen J Weinberg, et al. 2007 A higher dose of vitamin d reduces the risk of falls in nursing home residents: a randomized, multiple-dose study J Am Geriatr Soc. 55 2 234 239 10.1111/j.1532-5415.2007.01048.x 17302660 (Pubitemid 46184399)
17. FM Gloth III 1999 Alam W, Hollis B: Vitamin D vs. broad spectrum phototherapy in the treatment of seasonal effective disorder J Nutr Health Aging 3 5 7 10888476
18. CH Wilkins SJ Birge YI Sheline JC Morris 2009 Vitamin D deficiency is associated with worse cognitive performance and lower bone density in older African Americans J Natl Med Assoc. 101 4 349 354 19397226
19. ML Evatt MR Delong N Khazai, et al. 2008 Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease Arch Neurol. 65 10 1348 1352 10.1001/archneur.65.10.1348 18852350
20. AG Pittas J Lau FB Hu B Dawson-Hughes 2007 The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis J Clin Endocrinol Metab. 92 6 2017 2029 1:CAS:528:DC%2BD2sXmslOhtbs%3D 10.1210/jc.2007-0298 17389701 (Pubitemid 46997093)
21. JA Johnson JP Grande PC Roche R Kumar 1994 Immunohistochemical localization of the 1, 25(OH)2D3 receptor and calbindin D28k in human and rat pancreas Am J Physiol. 267 E356 E360 1:CAS:528:DyaK2MXisF2lsrw%3D 7943215
22. R Bland D Markovic CE Hills, et al. 2004 Expression of 25-hydroxyvitamin D3-1-hydroxylase in pancreatic islets J Steroid Biochem Mol Biol. 89-90 121 125 10.1016/j.jsbmb.2004.03.115 15225758 (Pubitemid 38844271)
23. E Hypponen E Laara A Reunanen, et al. 2001 Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study Lancet 358 1500 1503 1:STN:280:DC%2BD3MnltFKqsA%3D%3D 10.1016/S0140-6736(01)06580-1 11705562 (Pubitemid 33055701)
24. E Orwoll M Riddle M Prince 1994 Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus Am J Clin Nutr. 59 1083 1087 1:CAS:528:DyaK2cXltVOit70%3D 8172095
25. AG Pittas SS Harris PC Stark B Dawson-Hughes 2007 The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in non-diabetic adults Diabetes Care. 30 980 986 1:CAS:528:DC%2BD2sXkvVOns78%3D 10.2337/dc06-1994 17277040 (Pubitemid 46556596)
26. AG Pittas B Dawson-Hughes T Li, et al. 2006 Vitamin D and calcium intake in relation to type 2 diabetes in women Diabetes Care 29 650 656 1:CAS:528:DC%2BD28XislOksbg%3D 10.2337/diacare.29.03.06.dc05-1961 16505521
27. A Zittermann 2006 Vitamin D and disease prevention with special reference to cardiovascular disease Prog Biophys Mol Biol 92 39 48 1:CAS:528: DC%2BD28XlsFKrsb0%3D 10.1016/j.pbiomolbio.2006.02.001 16600341 (Pubitemid 43831966)
28. FR Pérez-López 2009 Vitamin D metabolism and cardiovascular risk factors in postmenopausal women Maturitas. 62 3 248 262 10.1016/j.maturitas.2008.12.020 19211206
29. R Heaney M Dowell C Hale A Bendich 2003 Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D J. Am. Coll. Nutr. 22 142 146 1:CAS:528:DC%2BD3sXjtlelsLw%3D 12672710
30. YC Li 2003 Vitamin D regulation of the renin-angiotensin system J Cell Biochem 88 327 331 1:CAS:528:DC%2BD3sXntlyktQ%3D%3D 10.1002/jcb.10343 12520534 (Pubitemid 36119906)
31. SG Rostand 1997 Ultraviolet light may contribute to geographic and racial blood pressure differences Hypertension 30 150 156 1:CAS:528:DyaK2sXls1ymtbg%3D 9260973
32. R Krause M Buhring W Hopfenmuller, et al. 1998 Ultraviolet B and blood pressure Lancet 352 709 710 1:STN:280:DyaK1czpslaitg%3D%3D 10.1016/S0140- 6736(05)60827-6 9728997
33. E Giovannucci Y Liu EB Rimm, et al. 2006 Prospective study of predictors of vitamin D status and cancer incidence and mortality in men J Natl Cancer Inst 98 451 459 1:CAS:528:DC%2BD28Xjtlamt7k%3D 10.1093/jnci/djj101 16595781
34. HF Deluca MT Cantorna 2001 Vitamin D: its role and uses in immunology FASEB J. 15 14 2579 2585 1:CAS:528:DC%2BD3MXptFamsbs%3D 10.1096/fj.01-0433rev 11726533 (Pubitemid 33131084)
35. MT Cantorna Y Zhu M Froicu A Wittke 2004 Vitamin D status, 1, 25-dihydroxyvitamin D3, and the immune system Am J Clin Nutr 80 Suppl 6 1717S 1720S 1:CAS:528:DC%2BD2cXhtFaisrjO 15585793
36. MT Cantorna DA Hullett C Redaelli, et al. 1998 1, 25-Dihydroxyvitamin D3 prolongs graft survival without compromising host resistance to infection or bone mineral density Transplantation. 66 7 828 831 1:CAS:528:DyaK1cXnt1Kku70%3D 10.1097/00007890-199810150-00003 9798689 (Pubitemid 28487453)
37. LM Bodnar HN Simhan RW Powers, et al. 2007 High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates J Nutr 137 2 447 452 1:CAS:528:DC%2BD2sXhsVWju7w%3D 17237325
38. CM Gordon KC DePeter HA Feldman, et al. 2004 Prevalence of vitamin D deficiency among healthy adolescents Arch Pediatr Adolesc Med 158 531 537 10.1001/archpedi.158.6.531 15184215 (Pubitemid 38720483)
39. Ginde AA, Liu MC, Camaargo CA: Demographic Differences and Trends of Vitamin D Insifficiency in the US Population, 1988-2004. Arch Intern Med. 2009; 626-632.
40. G Guaraldi G Orlando N Squillace, et al. 2006 Prevalence of secondary causes of osteoporosis among HIV-infected individuals Antiviral Therapy. 11 7 L9
41. M Rodríguez B Daniels S Gunawardene GK Robbins 2009 High frequency of vitamin D deficiency in ambulatory HIV-Positive patients AIDS Res Hum Retroviruses. 25 1 9 14 10.1089/aid.2008.0183 19108690
42. • Dao CN, Patel P, Overton ET, et al., and the Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN) Investigators: Prevalence of and risk factors for low levels of vitamin D in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin Infect Dis, in press. This article provides recent data comparing vitamin D levels among HIV-infected and HIV-negative persons in the United States.
43. • Stein EM, Yin MT, McMahon DJ, et al.: Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women. Osteoporos Int 2010 (Epub ahead of print). This article provides recent data highlighting the epidemic of vitamin D deficiency among postmenopausal women in the United States.
44. MT Yin D Lu S Cremers, et al. 2010 Short-term bone loss in HIV-infected premenopausal women J Acquir Immune Defic Syndr. 53 2 202 208 10.1097/QAI.0b013e3181bf6471 19890216
45. UC Bang SA Shakar MF Hitz, et al. 2010 Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study Scand J Infect Dis. 42 4 306 310 1:CAS:528:DC%2BC3cXjtFKitbs%3D 10.3109/ 00365540903463981 20085419
46. Borderi M, Vescini F, Cozzi-Lepri A, et al.: 2010 Prevalence of hypovitaminosis D among HIV∈+∈patients enrolled in a large Italian cohort. Presented at the 17th Conference on Retroviruses and Opportunistic Infections; San Francisco, CA; February 16-19, 2010.
47. NJ Mueller CA Fux B Ledergerber, et al. 2010 High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients AIDS. 24 8 1127 1134 1:CAS:528:DC%2BC3cXlsVOmsb4%3D 10.1097/QAD.0b013e328337b161 20168200
48. T Welz K Childs F Ibrahim, et al. 2010 Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase AIDS. 24 12 1923 1928 1:CAS:528:DC%2BC3cXos1WqtrY%3D 10.1097/QAD.0b013e32833c3281 20588161
49. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, et al.: Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses. 2008 Nov;24(11):1375-1382.
50. S Christakos DV Ajibade P Dhawan, et al. 2010 Vitamin D: metabolism Endocrinol Metab Clin North Am. 39 2 243 253 1:CAS:528:DC%2BC3cXpsFKgt7c%3D 10.1016/j.ecl.2010.02.002 20511049
51. G Madeddu A Spanu P Solinas, et al. 2004 Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy Q J Nucl Med Mol Imaging 48 1 39 48 15195003
52. J Fernandez-Rivera R Garcia F Lozano, et al. 2003 Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients HIV Clin Trials 4 5 337 346 1:STN:280:DC%2BD3srgs1yltw%3D%3D 10.1310/4X0H-UVMJ-BHYW-CPFB 14583850 (Pubitemid 37304437)
53. McComsey GA, Kitch D, Daar E, et al.: Bone and limb fat outcomes of ACTG A5224s, a substudy of ACTG A5202: a prospective, randomized, partially blinded phase III trial of ABC/3TC or TDF/FTC with EFV or ATV/r for initial treatment of HIV-1 infection [abstract 106LB]. In: Program and abstracts of the 17th Conference on Retroviruses and Opportunistic Infections February 16-19, 2010, San Francisco, CA.
54. C Duvivier S Kolta L Assoumou, et al. 2009 Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients AIDS 23 7 817 824 10.1097/QAD.0b013e328328f789 19363330
55. M Cozzolino M Vidal 2003 Vittoria Arcidiacono M, et al.: HIV-protease inhibitors impair vitamin D bioactivation to 1, 25-dihydroxyvitamin D AIDS 17 513 520 1:CAS:528:DC%2BD3sXhsVSltL8%3D 10.1097/00002030-200303070-00006 12598771 (Pubitemid 36293104)
56. K Gyllensten F Josephson K Lidman M Saaf 2006 Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59N AIDS 20 14 1906 1907 10.1097/01.aids.0000244216. 08327.39 16954738 (Pubitemid 44358915)
57. G Fabbriciani 2009 De Socio GV: Efavirenz and bone health AIDS 23 9 1181 10.1097/QAD.0b013e32832bab0f 19451795
58. C Herzmann K Arasteh 2009 Efavirenz-induced osteomalacia AIDS 23 2 274 275 10.1097/QAD.0b013e32831f4685 19098501
59. TT Brown GA McComsey 2010 Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D Antivir Ther 15 3 425 429 1:CAS:528:DC%2BC3cXovV2ktbo%3D 10.3851/IMP1502 20516561 The authors highlight the impact of various antiretroviral agents on vitamin D metabolism
60. Welz T, Childs K, Ibrahim F, et al.: Efavirenz use is associated with severe vitamin D deficiency in a large, ethnically diverse urban UK HIV cohort. Program and Abstracts of 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Cape Town, South Africa; 2009.
61. Fox J, Peters B, Prakash M, et al.: Improvement in vitamin D deficiency following antiretroviral regime change: results from the MONET trial. AIDS Res Hum Retroviruses. 2010 (Epub ahead of print).
62. HA Valsamis SK Arora B Labban SI McFarlane 2006 Antiepileptic drugs and bone metabolism Nutr Metab (Lond) 3 36 10.1186/1743-7075-3-36 (Pubitemid 44520436)
63. JM Pascussi A Robert M Nguyen, et al. 2005 Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia J Clin Invest 115 177 186 1:CAS:528:DC%2BD2MXis1eqtA%3D%3D 15630458
64. E Lattuada M Lanzafame G Zoppini, et al. 2009 No influence of nevirapine on vitamin D deficiency in HIV-infected patients AIDS Research and Human Retroviruses 25 8 849 850 1:CAS:528:DC%2BD1MXhtVWntbfK 10.1089/aid.2009.0063 19618997
65. Cervero M, Alcazar V, Garcia-LaCalle C, et al.: Prevalence of vitamin D deficiency in HIV infection. Abstract H-230. ICAAC 2010; Boston, MA.
66. Pasquet A, Viget N, Choisy P, et al.: Prevalence and risk factors for hypovitaminosis D among HIV-infected patients in a French HIV Clinical Cohort. Abstracts H-225. ICAAC 2010; Boston, MA.
67. JE Gallant S Staszewski AL Pozniak, et al. 2004 Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral naive patients: a 3-year randomized trial JAMA. 292 2 191 201 1:CAS:528: DC%2BD2cXlvVSnur0%3D 10.1001/jama.292.2.191 15249568 (Pubitemid 38917996)
68. Cooper DA, Bloch M, Humphries A, et al.: Simplification with fixed dose tenofovir-emtricitaine or abacavir-lamivudine in adults with suppressed HIV repliation (The Steal Study): A randomized, open-label, 96-week, non-inferiority trial [abstract 576]. In Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections February 8-11, 2009, Montreal, Canada.
69. P Labarga P Barreiro L Martin-Carbonero, et al. 2009 Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir AIDS. 23 6 689 696 1:CAS:528:DC%2BD1MXivFeqtr8%3D 10.1097/QAD.0b013e3283262a64 19262355
70. CA Fux A Rauch M Simcock, et al. 2008 Swiss HIV Cohort Study Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study. Antivir Ther. 13 8 1077 1082 1:CAS:528:DC%2BD1MXhvVKlu74%3D
71. MM Rosenvinge K Gedela AJ Copas, et al. 2010 Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency J Acquir Immune Defic Syndr. 54 5 496 499 1:CAS:528: DC%2BC3cXptVylsr4%3D 10.1097/QAI.0b013e3181caebaa 20672448
72. BL Clarke AG Wynne DM Wilson LA Fitzpatrick 1995 Osteomalacia associated with adult Fanconi's syndrome: clinical and diagnostic features Clin Endocrinol (Oxf). 43 4 479 490 1:STN:280:DyaK28%2Fks1ynsg%3D%3D 10.1111/j.1365-2265.1995. tb02621.x
73. Overton ET, Mondy K, Bush T, et al.: Factors Associated with Low Bone Mineral Density in a Large Cohort of HIV-infected US Adults: Baseline Results from the SUN Study. Proceedings of the 14th Conference on Retroviruses and Opportunistic Infections 2007. Los Angeles, CA: Abstract 836.
74. JH Arnsten R Freeman AA Howard, et al. 2007 Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection AIDS. 21 5 617 623 10.1097/QAD.0b013e3280148c05 17314524
75. Dao C, Young B, Buchacz K, et al., and the HIV Outpatient Study Investigators: Higher and Increasing Rates of Fracture among HIV-infected Persons in the HIV Outpatient Study Compared to the General US Population, 1994 to 2008. Abstract 128. In: Program and abstracts of the 17th Conference on Retroviruses and Opportunistic Infections February 16-19, 2010, San Francisco, CA.
76. Womack J, Goulet J, Gibert C, et al., and Veterans Aging Cohort Project Team: HIV-Infection and Fragility Fracture Risk among Male Veterans. Abstract 129. In: Program and abstracts of the 17th Conference on Retroviruses and Opportunistic Infections February 16-19, 2010, San Francisco, CA.
77. th Conference on Retroviruses and Opportunistic Infections 2007. Los Angeles, CA: Abstract 837.
78. B Grund G Peng CL Gibert, et al. 2009 INSIGHT SMART Body Composition Substudy Group: Continuous antiretroviral therapy (ART) decreases bone mineral density AIDS 23 12 1519 1529 1:CAS:528:DC%2BD1MXovVSgs7g%3D 10.1097/QAD. 0b013e32832c1792 19531929 This article provides data from the SMART study highlighting the negative impact of cART on bone health
79. K Mondy WG Powderly SA Claxton, et al. 2005 Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection J Acquir Immune Defic Syndr. 38 4 426 431 1:CAS:528: DC%2BD2MXit1ekt7Y%3D 10.1097/01.qai.0000145352.04440.1e 15764959 (Pubitemid 40381552)
80. GA McComsey MA Kendall P Tebas, et al. 2007 Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV AIDS. 21 18 2473 2482 1:CAS:528:DC%2BD2sXhtlWjtL3P 10.1097/QAD.0b013e3282ef961d 18025884 (Pubitemid 350145179)
81. JP Schneider 2009 Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk Geriatrics. 64 1 18 23 19256578
82. W Strampel R Emkey R Civitelli 2007 Safety considerations with bisphosphonates for the treatment of osteoporosis Drug Saf. 30 9 755 763 1:CAS:528:DC%2BD2sXht1amsb7F 10.2165/00002018-200730090-00003 17722968 (Pubitemid 47351214)
83. Shane E, Burr D, Ebeling PR, et al.: Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2010 (Epub ahead of print).
84. C Buitrago R Boland AR de Boland 2001 The tyrosine kinase c-Src is required for 1, 25(OH)2-vitamin D3 signalling to the nucleus in muscle cells Biochim Biophys Acta. 1541 3 179 187 1:CAS:528:DC%2BD38XitFSm 10.1016/S0167-4889(01)00142-2 11755212 (Pubitemid 34045125)
85. C Buitrago G Vazquez AR De Boland R Boland 2001 The vitamin D receptor mediates rapid changes in muscle protein tyrosine phosphorylation induced by 1, 25(OH)(2)D(3) Biochem Biophys Res Commun. 289 5 1150 1156 1:CAS:528: DC%2BD3MXptVWjsLo%3D 10.1006/bbrc.2001.6072 11741312 (Pubitemid 34076311)
86. V Kumar S Mukhopadhyay 2008 Singh Bedi P, et al.: A novel modulatory role of vitamin D3 in exercise-induced apoptosis of rat skeletal muscle. Am J Food Technol 3 361 372 1:CAS:528:DC%2BD1cXhtlaitL7I 10.3923/ajft.2008.361.372 (Pubitemid 352846229)
87. R Boland 1986 Role of vitamin D in skeletal muscle function Endocr Rev. 7 4 434 448 1:CAS:528:DyaL2sXkvFSitA%3D%3D 10.1210/edrv-7-4-434 3536463
88. S Yoshikawa T Nakamura H Tanabe T Imamura 1979 Osteomalacic myopathy Endocrinol Jpn. 26 Suppl 65 72 1:STN:280:DyaE1M3js1ajsQ%3D%3D 467350
89. Y Sato J Iwamoto T Kanoko K Satoh 2005 Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial Cerebrovasc Dis. 20 3 187 92 1:CAS:528: DC%2BD2MXpslCmsrY%3D 10.1159/000087203 16088114 (Pubitemid 41254180)
90. L Ceglia 2009 Vitamin D and its role in skeletal muscle Curr Opin Clin Nutr Metab Care 12 6 628 633 1:CAS:528:DC%2BD1MXht1Kju7jI 10.1097/MCO. 0b013e328331c707 19770647 This article provides a comprehensive review of effects of vitamin D on muscle health
91. TT Dam D von Mühlen EL Barrett-Connor 2009 Sex-specific association of serum vitamin D levels with physical function in older adults Osteoporos Int. 20 5 751 760 1:CAS:528:DC%2BD1MXjvFaqtrc%3D 10.1007/s00198-008-0749-1 18802657
92. NO Kuchuk SM Pluijm NM van Schoor, et al. 2009 Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons J Clin Endocrinol Metab. 94 4 1244 1250 10.1210/jc.2008-1832 19158198
93. G El-Hajj Fuleihan M Nabulsi H Tamim, et al. 2006 Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial J Clin Endocrinol Metab 91 2 405 412 10.1210/jc.2005-1436 16278262 (Pubitemid 43236902)
94. HA Bischoff HB Stähelin W Dick, et al. 2003 Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial J Bone Miner Res. 18 2 343 351 1:CAS:528:DC%2BD3sXht1Sktrs%3D 10.1359/jbmr.2003.18.2.343 12568412 (Pubitemid 36125927)
95. M Pfeifer B Begerow HW Minne, et al. 2009 Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals Osteoporos Int. 20 2 315 322 1:CAS:528:DC%2BD1MXktVSgtQ%3D%3D 10.1007/s00198-008-0662-7 18629569
96. HA Bischoff-Ferrari WC Willett JB Wong, et al. 2005 Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials JAMA. 293 18 2257 2264 1:CAS:528:DC%2BD2MXktFOntb8%3D 10.1001/jama.293.18.2257 15886381 (Pubitemid 40629192)
97. TT Brown SR Cole X Li, et al. 2005 Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study Arch Intern Med. 165 1179 1184 10.1001/archinte.165.10.1179 15911733 (Pubitemid 40720744)
98. JE Justman L Benning A Danoff, et al. 2003 Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women J Acquir Immune Defic Syndr. 32 298 302 1:CAS:528:DC%2BD3sXhslGjsLs%3D 10.1097/00126334-200303010-00009 12626890 (Pubitemid 36331702)
99. P Tebas 2008 Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention, and treatment options J Acquir Immune Defic Syndr. 49 Suppl 2 S86 S92 1:CAS:528:DC%2BD1cXhtVejs7rE 18725817
100. CJ Rosen A Klibanski 2009 Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis Am J Med. 122 5 409 414 1:CAS:528:DC%2BD1MXkslGltrc%3D 10.1016/j.amjmed.2008.11.027 19375545
101. MW Hamrick SL Ferrari 2008 Leptin and the sympathetic connection of fat to bone Osteoporos Int. 19 7 905 912 1:CAS:528:DC%2BD1cXmsFKnuro%3D 10.1007/s00198-007-0487-9 17924050 (Pubitemid 351758616)
102. P Ducy M Amling S Takeda, et al. 2000 Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass Cell. 100 2 197 207 1:CAS:528:DC%2BD3cXotFChsw%3D%3D 10.1016/S0092-8674(00)81558-5 10660043
103. NK Lee H Sowa E Hinoi, et al. 2007 Endocrine regulation of energy metabolism by the skeleton Cell. 130 3 456 469 1:CAS:528:DC%2BD2sXptlyntbs%3D 10.1016/j.cell.2007.05.047 17693256 (Pubitemid 47208519)
104. C Mathieu K Casteels M Waer, et al. 1998 Prevention of diabetes recurrence after syngeneic islet transplantation in NOD mice by analogues of 1, 25(OH)2D3 in combination with cyclosporin A: mechanism of action involves an immune shift from Th1 to Th2 Transplant Proc 30 2 541 1:STN:280: DyaK1c7ptlegtQ%3D%3D 10.1016/S0041-1345(97)01398-5 9532170 (Pubitemid 28207291)
105. BD Jamieson DC Douek S Killian, et al. 1999 Generation of functional thymocytes in the human adult Immunity 10 569 575 1:CAS:528:DyaK1MXjslamur0%3D 10.1016/S1074-7613(00)80056-4 10367902 (Pubitemid 29262659)
106. GM Aldrovandi G Feuer L Gao, et al. 1993 The SCID-hu mouse as a model for HIV-1 infection Nature 363 732 736 1:CAS:528:DyaK3sXltFGiu74%3D 10.1038/363732a0 8515816 (Pubitemid 23227652)
107. V Appay SL Rowland-Jones 2002 Premature ageing of the immune system: the cause of AIDS? Trends in Immunology 23 12 580 585 1:CAS:528:DC%2BD38XptFGmurk%3D 10.1016/S1471-4906(02)02338-4 12464569 (Pubitemid 35449096)
108. AA Luciano MM Lederman A Valentin-Torres, et al. 2007 Impaired induction of CD27 and CD28 predicts naïve CD4 T cell proliferation defects in HIV disease J Immunol. 179 6 3543 3549 1:CAS:528:DC%2BD2sXpvFKlsrs%3D 17785788
109. SM Arpadi D McMahon EJ Abrams, et al. 2009 Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents Pediatrics 123 1 e121 6 10.1542/peds.2008-0176 19117833 Erratum in: Pediatrics. 2009 May;123(5):1437
110. S Mehta E Giovannucci FM Mugusi, et al. 2010 Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality PLoS One 5 1 e8770 10.1371/journal.pone.0008770 20098738
111. S Mehta DJ Hunter FM Mugusi, et al. 2009 Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania J Infect Dis. 200 7 1022 1030 1:CAS:528:DC%2BD1MXht1OgsbbL 10.1086/605699 19673647
112. European AIDS Clinical Society: Guidelines: prevention and management of non-infectious co-morbidities in HIV. Available at http://www. europeanaidsclinicalsociety.org/guidelinespdf/2-Non-Infectious-Co-Morbidities- in-HIV.pdf. Accessed September 2010.
113. JA Aberg JE Kaplan H Libman, et al. 2009 HIV Medicine Association of the Infectious Diseases Society of America: Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America Clin Infect Dis. 49 5 651 681 10.1086/605292 19640227
114. Holick MF: Vitamin D: Evolutionary, physiological and health perspectives. Curr Drug Targets 2010 (Epub ahead of print).
115. RP Heaney 2008 Vitamin D: criteria for safety and efficacy Nutr Rev. 66 10 Suppl 2 S178 S181 10.1111/j.1753-4887.2008.00102.x 18844846